Summary
Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.
According to APO Research, The global Diagnostic Radiopharmaceuticals market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Diagnostic Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Diagnostic Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Diagnostic Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Diagnostic Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Diagnostic Radiopharmaceuticals include Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, Advanced Accelerator Applications, SIEMENS, China Isotope & Radiation and Dongcheng Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Diagnostic Radiopharmaceuticals, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Diagnostic Radiopharmaceuticals, also provides the sales of main regions and countries. Of the upcoming market potential for Diagnostic Radiopharmaceuticals, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Diagnostic Radiopharmaceuticals sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Diagnostic Radiopharmaceuticals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Diagnostic Radiopharmaceuticals sales, projected growth trends, production technology, application and end-user industry.
Diagnostic Radiopharmaceuticals segment by Company
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
Diagnostic Radiopharmaceuticals segment by Type
Technetium 99
Fluorine 18
Other
Diagnostic Radiopharmaceuticals segment by Application
Oncology
Cardiology
Other
Diagnostic Radiopharmaceuticals segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Radiopharmaceuticals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Diagnostic Radiopharmaceuticals in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Diagnostic Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diagnostic Radiopharmaceuticals sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Diagnostic Radiopharmaceuticals Market by Type
1.2.1 Global Diagnostic Radiopharmaceuticals Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Diagnostic Radiopharmaceuticals Market by Application
1.3.1 Global Diagnostic Radiopharmaceuticals Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Diagnostic Radiopharmaceuticals Market Dynamics
2.1 Diagnostic Radiopharmaceuticals Industry Trends
2.2 Diagnostic Radiopharmaceuticals Industry Drivers
2.3 Diagnostic Radiopharmaceuticals Industry Opportunities and Challenges
2.4 Diagnostic Radiopharmaceuticals Industry Restraints
3 Global Market Growth Prospects
3.1 Global Diagnostic Radiopharmaceuticals Revenue Estimates and Forecasts (2019-2030)
3.2 Global Diagnostic Radiopharmaceuticals Revenue by Region
3.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Diagnostic Radiopharmaceuticals Revenue by Region (2019-2024)
3.2.3 Global Diagnostic Radiopharmaceuticals Revenue by Region (2025-2030)
3.2.4 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2019-2030)
3.3 Global Diagnostic Radiopharmaceuticals Sales Estimates and Forecasts 2019-2030
3.4 Global Diagnostic Radiopharmaceuticals Sales by Region
3.4.1 Global Diagnostic Radiopharmaceuticals Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Diagnostic Radiopharmaceuticals Sales by Region (2019-2024)
3.4.3 Global Diagnostic Radiopharmaceuticals Sales by Region (2025-2030)
3.4.4 Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Diagnostic Radiopharmaceuticals Revenue by Manufacturers
4.1.1 Global Diagnostic Radiopharmaceuticals Revenue by Manufacturers (2019-2024)
4.1.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Diagnostic Radiopharmaceuticals Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Diagnostic Radiopharmaceuticals Sales by Manufacturers
4.2.1 Global Diagnostic Radiopharmaceuticals Sales by Manufacturers (2019-2024)
4.2.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Diagnostic Radiopharmaceuticals Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Diagnostic Radiopharmaceuticals Sales Price by Manufacturers (2019-2024)
4.4 Global Diagnostic Radiopharmaceuticals Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Diagnostic Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Diagnostic Radiopharmaceuticals Manufacturers, Product Type & Application
4.7 Global Diagnostic Radiopharmaceuticals Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Diagnostic Radiopharmaceuticals Market CR5 and HHI
4.8.2 2023 Diagnostic Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
5 Diagnostic Radiopharmaceuticals Market by Type
5.1 Global Diagnostic Radiopharmaceuticals Revenue by Type
5.1.1 Global Diagnostic Radiopharmaceuticals Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
5.2 Global Diagnostic Radiopharmaceuticals Sales by Type
5.2.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Diagnostic Radiopharmaceuticals Sales by Type (2019-2030) & (K Units)
5.2.3 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2019-2030)
5.3 Global Diagnostic Radiopharmaceuticals Price by Type
6 Diagnostic Radiopharmaceuticals Market by Application
6.1 Global Diagnostic Radiopharmaceuticals Revenue by Application
6.1.1 Global Diagnostic Radiopharmaceuticals Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
6.2 Global Diagnostic Radiopharmaceuticals Sales by Application
6.2.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Diagnostic Radiopharmaceuticals Sales by Application (2019-2030) & (K Units)
6.2.3 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2019-2030)
6.3 Global Diagnostic Radiopharmaceuticals Price by Application
7 Company Profiles
7.1 Cardinal Health
7.1.1 Cardinal Health Comapny Information
7.1.2 Cardinal Health Business Overview
7.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio
7.1.5 Cardinal Health Recent Developments
7.2 GE Healthcare
7.2.1 GE Healthcare Comapny Information
7.2.2 GE Healthcare Business Overview
7.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio
7.2.5 GE Healthcare Recent Developments
7.3 Curium Pharma
7.3.1 Curium Pharma Comapny Information
7.3.2 Curium Pharma Business Overview
7.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio
7.3.5 Curium Pharma Recent Developments
7.4 Jubilant Pharma
7.4.1 Jubilant Pharma Comapny Information
7.4.2 Jubilant Pharma Business Overview
7.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio
7.4.5 Jubilant Pharma Recent Developments
7.5 Bracco Imaging
7.5.1 Bracco Imaging Comapny Information
7.5.2 Bracco Imaging Business Overview
7.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio
7.5.5 Bracco Imaging Recent Developments
7.6 Advanced Accelerator Applications
7.6.1 Advanced Accelerator Applications Comapny Information
7.6.2 Advanced Accelerator Applications Business Overview
7.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio
7.6.5 Advanced Accelerator Applications Recent Developments
7.7 SIEMENS
7.7.1 SIEMENS Comapny Information
7.7.2 SIEMENS Business Overview
7.7.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio
7.7.5 SIEMENS Recent Developments
7.8 China Isotope & Radiation
7.8.1 China Isotope & Radiation Comapny Information
7.8.2 China Isotope & Radiation Business Overview
7.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio
7.8.5 China Isotope & Radiation Recent Developments
7.9 Dongcheng Pharmaceutical Group
7.9.1 Dongcheng Pharmaceutical Group Comapny Information
7.9.2 Dongcheng Pharmaceutical Group Business Overview
7.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio
7.9.5 Dongcheng Pharmaceutical Group Recent Developments
7.10 Lantheus
7.10.1 Lantheus Comapny Information
7.10.2 Lantheus Business Overview
7.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Lantheus Diagnostic Radiopharmaceuticals Product Portfolio
7.10.5 Lantheus Recent Developments
7.11 Eli Lilly
7.11.1 Eli Lilly Comapny Information
7.11.2 Eli Lilly Business Overview
7.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio
7.11.5 Eli Lilly Recent Developments
8 North America
8.1 North America Diagnostic Radiopharmaceuticals Market Size by Type
8.1.1 North America Diagnostic Radiopharmaceuticals Revenue by Type (2019-2030)
8.1.2 North America Diagnostic Radiopharmaceuticals Sales by Type (2019-2030)
8.1.3 North America Diagnostic Radiopharmaceuticals Price by Type (2019-2030)
8.2 North America Diagnostic Radiopharmaceuticals Market Size by Application
8.2.1 North America Diagnostic Radiopharmaceuticals Revenue by Application (2019-2030)
8.2.2 North America Diagnostic Radiopharmaceuticals Sales by Application (2019-2030)
8.2.3 North America Diagnostic Radiopharmaceuticals Price by Application (2019-2030)
8.3 North America Diagnostic Radiopharmaceuticals Market Size by Country
8.3.1 North America Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Diagnostic Radiopharmaceuticals Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Diagnostic Radiopharmaceuticals Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Diagnostic Radiopharmaceuticals Market Size by Type
9.1.1 Europe Diagnostic Radiopharmaceuticals Revenue by Type (2019-2030)
9.1.2 Europe Diagnostic Radiopharmaceuticals Sales by Type (2019-2030)
9.1.3 Europe Diagnostic Radiopharmaceuticals Price by Type (2019-2030)
9.2 Europe Diagnostic Radiopharmaceuticals Market Size by Application
9.2.1 Europe Diagnostic Radiopharmaceuticals Revenue by Application (2019-2030)
9.2.2 Europe Diagnostic Radiopharmaceuticals Sales by Application (2019-2030)
9.2.3 Europe Diagnostic Radiopharmaceuticals Price by Application (2019-2030)
9.3 Europe Diagnostic Radiopharmaceuticals Market Size by Country
9.3.1 Europe Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Diagnostic Radiopharmaceuticals Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Diagnostic Radiopharmaceuticals Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Diagnostic Radiopharmaceuticals Market Size by Type
10.1.1 China Diagnostic Radiopharmaceuticals Revenue by Type (2019-2030)
10.1.2 China Diagnostic Radiopharmaceuticals Sales by Type (2019-2030)
10.1.3 China Diagnostic Radiopharmaceuticals Price by Type (2019-2030)
10.2 China Diagnostic Radiopharmaceuticals Market Size by Application
10.2.1 China Diagnostic Radiopharmaceuticals Revenue by Application (2019-2030)
10.2.2 China Diagnostic Radiopharmaceuticals Sales by Application (2019-2030)
10.2.3 China Diagnostic Radiopharmaceuticals Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Diagnostic Radiopharmaceuticals Market Size by Type
11.1.1 Asia Diagnostic Radiopharmaceuticals Revenue by Type (2019-2030)
11.1.2 Asia Diagnostic Radiopharmaceuticals Sales by Type (2019-2030)
11.1.3 Asia Diagnostic Radiopharmaceuticals Price by Type (2019-2030)
11.2 Asia Diagnostic Radiopharmaceuticals Market Size by Application
11.2.1 Asia Diagnostic Radiopharmaceuticals Revenue by Application (2019-2030)
11.2.2 Asia Diagnostic Radiopharmaceuticals Sales by Application (2019-2030)
11.2.3 Asia Diagnostic Radiopharmaceuticals Price by Application (2019-2030)
11.3 Asia Diagnostic Radiopharmaceuticals Market Size by Country
11.3.1 Asia Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Diagnostic Radiopharmaceuticals Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Diagnostic Radiopharmaceuticals Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Diagnostic Radiopharmaceuticals Market Size by Type
12.1.1 MEALA Diagnostic Radiopharmaceuticals Revenue by Type (2019-2030)
12.1.2 MEALA Diagnostic Radiopharmaceuticals Sales by Type (2019-2030)
12.1.3 MEALA Diagnostic Radiopharmaceuticals Price by Type (2019-2030)
12.2 MEALA Diagnostic Radiopharmaceuticals Market Size by Application
12.2.1 MEALA Diagnostic Radiopharmaceuticals Revenue by Application (2019-2030)
12.2.2 MEALA Diagnostic Radiopharmaceuticals Sales by Application (2019-2030)
12.2.3 MEALA Diagnostic Radiopharmaceuticals Price by Application (2019-2030)
12.3 MEALA Diagnostic Radiopharmaceuticals Market Size by Country
12.3.1 MEALA Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Diagnostic Radiopharmaceuticals Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Diagnostic Radiopharmaceuticals Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Diagnostic Radiopharmaceuticals Value Chain Analysis
13.1.1 Diagnostic Radiopharmaceuticals Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Diagnostic Radiopharmaceuticals Production Mode & Process
13.2 Diagnostic Radiopharmaceuticals Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Diagnostic Radiopharmaceuticals Distributors
13.2.3 Diagnostic Radiopharmaceuticals Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Technetium 99 Major Manufacturers
Table 3. Fluorine 18 Major Manufacturers
Table 4. Other Major Manufacturers
Table 5. Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Oncology Major Manufacturers
Table 7. Cardiology Major Manufacturers
Table 8. Other Major Manufacturers
Table 9. Diagnostic Radiopharmaceuticals Industry Trends
Table 10. Diagnostic Radiopharmaceuticals Industry Drivers
Table 11. Diagnostic Radiopharmaceuticals Industry Opportunities and Challenges
Table 12. Diagnostic Radiopharmaceuticals Industry Restraints
Table 13. Global Diagnostic Radiopharmaceuticals Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Diagnostic Radiopharmaceuticals Revenue by Region (2019-2024) & (US$ Million)
Table 15. Global Diagnostic Radiopharmaceuticals Revenue by Region (2025-2030) & (US$ Million)
Table 16. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2019-2024)
Table 17. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2025-2030)
Table 18. Global Diagnostic Radiopharmaceuticals Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Table 19. Global Diagnostic Radiopharmaceuticals Sales by Region (2019-2024) & (K Units)
Table 20. Global Diagnostic Radiopharmaceuticals Sales by Region (2025-2030) & (K Units)
Table 21. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2019-2024)
Table 22. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2025-2030)
Table 23. Global Diagnostic Radiopharmaceuticals Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 24. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
Table 25. Global Diagnostic Radiopharmaceuticals Sales by Manufacturers (US$ Million) & (2019-2024)
Table 26. Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
Table 27. Global Diagnostic Radiopharmaceuticals Sales Price (US$/Unit) of Manufacturers (2019-2024)
Table 28. Global Diagnostic Radiopharmaceuticals Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 29. Global Diagnostic Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters
Table 30. Global Diagnostic Radiopharmaceuticals Manufacturers, Product Type & Application
Table 31. Global Diagnostic Radiopharmaceuticals Manufacturers Commercialization Time
Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Diagnostic Radiopharmaceuticals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 34. Global Diagnostic Radiopharmaceuticals Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 35. Global Diagnostic Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 36. Global Diagnostic Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 37. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2019-2024)
Table 38. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2025-2030)
Table 39. Global Diagnostic Radiopharmaceuticals Sales by Type 2019 VS 2023 VS 2030 (K Units)
Table 40. Global Diagnostic Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 41. Global Diagnostic Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 42. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2019-2024)
Table 43. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2025-2030)
Table 44. Global Diagnostic Radiopharmaceuticals Price by Type (2019-2024) & (US$/Unit)
Table 45. Global Diagnostic Radiopharmaceuticals Price by Type (2025-2030) & (US$/Unit)
Table 46. Global Diagnostic Radiopharmaceuticals Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 47. Global Diagnostic Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 48. Global Diagnostic Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 49. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2019-2024)
Table 50. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2025-2030)
Table 51. Global Diagnostic Radiopharmaceuticals Sales by Application 2019 VS 2023 VS 2030 (K Units)
Table 52. Global Diagnostic Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 53. Global Diagnostic Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 54. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Table 55. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2025-2030)
Table 56. Global Diagnostic Radiopharmaceuticals Price by Application (2019-2024) & (US$/Unit)
Table 57. Global Diagnostic Radiopharmaceuticals Price by Application (2025-2030) & (US$/Unit)
Table 58. Cardinal Health Company Information
Table 59. Cardinal Health Business Overview
Table 60. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 61. Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio
Table 62. Cardinal Health Recent Development
Table 63. GE Healthcare Company Information
Table 64. GE Healthcare Business Overview
Table 65. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 66. GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio
Table 67. GE Healthcare Recent Development
Table 68. Curium Pharma Company Information
Table 69. Curium Pharma Business Overview
Table 70. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 71. Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio
Table 72. Curium Pharma Recent Development
Table 73. Jubilant Pharma Company Information
Table 74. Jubilant Pharma Business Overview
Table 75. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio
Table 77. Jubilant Pharma Recent Development
Table 78. Bracco Imaging Company Information
Table 79. Bracco Imaging Business Overview
Table 80. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio
Table 82. Bracco Imaging Recent Development
Table 83. Advanced Accelerator Applications Company Information
Table 84. Advanced Accelerator Applications Business Overview
Table 85. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio
Table 87. Advanced Accelerator Applications Recent Development
Table 88. SIEMENS Company Information
Table 89. SIEMENS Business Overview
Table 90. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio
Table 92. SIEMENS Recent Development
Table 93. China Isotope & Radiation Company Information
Table 94. China Isotope & Radiation Business Overview
Table 95. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio
Table 97. China Isotope & Radiation Recent Development
Table 98. Dongcheng Pharmaceutical Group Company Information
Table 99. Dongcheng Pharmaceutical Group Business Overview
Table 100. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio
Table 102. Dongcheng Pharmaceutical Group Recent Development
Table 103. Lantheus Company Information
Table 104. Lantheus Business Overview
Table 105. Lantheus Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Lantheus Diagnostic Radiopharmaceuticals Product Portfolio
Table 107. Lantheus Recent Development
Table 108. Eli Lilly Company Information
Table 109. Eli Lilly Business Overview
Table 110. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio
Table 112. Eli Lilly Recent Development
Table 113. North America Diagnostic Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 114. North America Diagnostic Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 115. North America Diagnostic Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 116. North America Diagnostic Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 117. North America Diagnostic Radiopharmaceuticals Sales Price by Type (2019-2024) & (US$/Unit)
Table 118. North America Diagnostic Radiopharmaceuticals Sales Price by Type (2025-2030) & (US$/Unit)
Table 119. North America Diagnostic Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 120. North America Diagnostic Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 121. North America Diagnostic Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 122. North America Diagnostic Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 123. North America Diagnostic Radiopharmaceuticals Sales Price by Application (2019-2024) & (US$/Unit)
Table 124. North America Diagnostic Radiopharmaceuticals Sales Price by Application (2025-2030) & (US$/Unit)
Table 125. North America Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 126. North America Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 127. North America Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 128. North America Diagnostic Radiopharmaceuticals Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 129. North America Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
Table 130. North America Diagnostic Radiopharmaceuticals Sales by Country (2025-2030) & (K Units)
Table 131. North America Diagnostic Radiopharmaceuticals Sales Price by Country (2019-2024) & (US$/Unit)
Table 132. North America Diagnostic Radiopharmaceuticals Sales Price by Country (2025-2030) & (US$/Unit)
Table 133. US Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 134. Canada Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 135. Europe Diagnostic Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 136. Europe Diagnostic Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 137. Europe Diagnostic Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 138. Europe Diagnostic Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 139. Europe Diagnostic Radiopharmaceuticals Sales Price by Type (2019-2024) & (US$/Unit)
Table 140. Europe Diagnostic Radiopharmaceuticals Sales Price by Type (2025-2030) & (US$/Unit)
Table 141. Europe Diagnostic Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 142. Europe Diagnostic Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 143. Europe Diagnostic Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 144. Europe Diagnostic Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 145. Europe Diagnostic Radiopharmaceuticals Sales Price by Application (2019-2024) & (US$/Unit)
Table 146. Europe Diagnostic Radiopharmaceuticals Sales Price by Application (2025-2030) & (US$/Unit)
Table 147. Europe Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 148. Europe Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 149. Europe Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 150. Europe Diagnostic Radiopharmaceuticals Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 151. Europe Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
Table 152. Europe Diagnostic Radiopharmaceuticals Sales by Country (2025-2030) & (K Units)
Table 153. Europe Diagnostic Radiopharmaceuticals Sales Price by Country (2019-2024) & (US$/Unit)
Table 154. Europe Diagnostic Radiopharmaceuticals Sales Price by Country (2025-2030) & (US$/Unit)
Table 155. Germany Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 156. France Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 157. Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 158. Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 159. Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 160. China Diagnostic Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 161. China Diagnostic Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 162. China Diagnostic Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 163. China Diagnostic Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 164. China Diagnostic Radiopharmaceuticals Sales Price by Type (2019-2024) & (US$/Unit)
Table 165. China Diagnostic Radiopharmaceuticals Sales Price by Type (2025-2030) & (US$/Unit)
Table 166. China Diagnostic Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 167. China Diagnostic Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 168. China Diagnostic Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 169. China Diagnostic Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 170. China Diagnostic Radiopharmaceuticals Sales Price by Application (2019-2024) & (US$/Unit)
Table 171. China Diagnostic Radiopharmaceuticals Sales Price by Application (2025-2030) & (US$/Unit)
Table 172. Asia Diagnostic Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 173. Asia Diagnostic Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 174. Asia Diagnostic Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 175. Asia Diagnostic Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 176. Asia Diagnostic Radiopharmaceuticals Sales Price by Type (2019-2024) & (US$/Unit)
Table 177. Asia Diagnostic Radiopharmaceuticals Sales Price by Type (2025-2030) & (US$/Unit)
Table 178. Asia Diagnostic Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 179. Asia Diagnostic Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 180. Asia Diagnostic Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 181. Asia Diagnostic Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 182. Asia Diagnostic Radiopharmaceuticals Sales Price by Application (2019-2024) & (US$/Unit)
Table 183. Asia Diagnostic Radiopharmaceuticals Sales Price by Application (2025-2030) & (US$/Unit)
Table 184. Asia Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 185. Asia Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 186. Asia Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 187. Asia Diagnostic Radiopharmaceuticals Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 188. Asia Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
Table 189. Asia Diagnostic Radiopharmaceuticals Sales by Country (2025-2030) & (K Units)
Table 190. Asia Diagnostic Radiopharmaceuticals Sales Price by Country (2019-2024) & (US$/Unit)
Table 191. Asia Diagnostic Radiopharmaceuticals Sales Price by Country (2025-2030) & (US$/Unit)
Table 192. Japan Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 193. South Korea Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 194. Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 195. Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 196. Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 197. Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 198. Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 199. Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 200. MEALA Diagnostic Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 201. MEALA Diagnostic Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 202. MEALA Diagnostic Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 203. MEALA Diagnostic Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 204. MEALA Diagnostic Radiopharmaceuticals Sales Price by Type (2019-2024) & (US$/Unit)
Table 205. MEALA Diagnostic Radiopharmaceuticals Sales Price by Type (2025-2030) & (US$/Unit)
Table 206. MEALA Diagnostic Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 207. MEALA Diagnostic Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 208. MEALA Diagnostic Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 209. MEALA Diagnostic Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 210. MEALA Diagnostic Radiopharmaceuticals Sales Price by Application (2019-2024) & (US$/Unit)
Table 211. MEALA Diagnostic Radiopharmaceuticals Sales Price by Application (2025-2030) & (US$/Unit)
Table 212. MEALA Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 213. MEALA Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 214. MEALA Diagnostic Radiopharmaceuticals Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 215. MEALA Diagnostic Radiopharmaceuticals Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 216. MEALA Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
Table 217. MEALA Diagnostic Radiopharmaceuticals Sales by Country (2025-2030) & (K Units)
Table 218. MEALA Diagnostic Radiopharmaceuticals Sales Price by Country (2019-2024) & (US$/Unit)
Table 219. MEALA Diagnostic Radiopharmaceuticals Sales Price by Country (2025-2030) & (US$/Unit)
Table 220. Mexico Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 221. Brazil Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 222. Israel Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 223. Argentina Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 224. Colombia Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 225. Turkey Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 226. Saudi Arabia Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 227. UAE Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Table 228. Key Raw Materials
Table 229. Raw Materials Key Suppliers
Table 230. Diagnostic Radiopharmaceuticals Distributors List
Table 231. Diagnostic Radiopharmaceuticals Customers List
Table 232. Research Programs/Design for This Report
Table 233. Authors List of This Report
Table 234. Secondary Sources
Table 235. Primary Sources
List of Figures
Figure 1. Diagnostic Radiopharmaceuticals Product Picture
Figure 2. Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Diagnostic Radiopharmaceuticals Market Size Share 2019 VS 2023 VS 2030
Figure 4. Technetium 99 Picture
Figure 5. Fluorine 18 Picture
Figure 6. Other Picture
Figure 7. Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Diagnostic Radiopharmaceuticals Market Size Share 2019 VS 2023 VS 2030
Figure 9. Oncology Picture
Figure 10. Cardiology Picture
Figure 11. Other Picture
Figure 12. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Diagnostic Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 14. Global Diagnostic Radiopharmaceuticals Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 15. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region: 2023 Versus 2030
Figure 16. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2019-2030)
Figure 17. Global Diagnostic Radiopharmaceuticals Sales (2019-2030) & (K Units)
Figure 18. Global Diagnostic Radiopharmaceuticals Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 19. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2019-2030)
Figure 20. US & Canada Diagnostic Radiopharmaceuticals Sales YoY (2019-2030) & (K Units)
Figure 21. Europe Diagnostic Radiopharmaceuticals Sales YoY (2019-2030) & (K Units)
Figure 22. China Diagnostic Radiopharmaceuticals Sales YoY (2019-2030) & (K Units)
Figure 23. Asia (Excluding China) Diagnostic Radiopharmaceuticals Sales YoY (2019-2030) & (K Units)
Figure 24. Middle East, Africa and Latin America (Excluding China) Diagnostic Radiopharmaceuticals Sales YoY (2019-2030) & (K Units)
Figure 25. Global Diagnostic Radiopharmaceuticals Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 26. Global Diagnostic Radiopharmaceuticals Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 28. Global Diagnostic Radiopharmaceuticals Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 29. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 30. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
Figure 31. Global Diagnostic Radiopharmaceuticals Sales by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 32. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 33. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2019-2030)
Figure 34. Global Diagnostic Radiopharmaceuticals Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 35. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 36. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
Figure 37. Global Diagnostic Radiopharmaceuticals Sales by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 38. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 39. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2019-2030)
Figure 40. North America Diagnostic Radiopharmaceuticals Revenue Share by Type (2019-2030)
Figure 41. North America Diagnostic Radiopharmaceuticals Sales Share by Type (2019-2030)
Figure 42. North America Diagnostic Radiopharmaceuticals Revenue Share by Application (2019-2030)
Figure 43. North America Diagnostic Radiopharmaceuticals Sales Share by Application (2019-2030)
Figure 44. North America Diagnostic Radiopharmaceuticals Revenue Share by Country (2019-2030)
Figure 45. North America Diagnostic Radiopharmaceuticals Sales Share by Country (2019-2030)
Figure 46. Europe Diagnostic Radiopharmaceuticals Revenue Share by Type (2019-2030)
Figure 47. Europe Diagnostic Radiopharmaceuticals Sales Share by Type (2019-2030)
Figure 48. Europe Diagnostic Radiopharmaceuticals Revenue Share by Application (2019-2030)
Figure 49. Europe Diagnostic Radiopharmaceuticals Sales Share by Application (2019-2030)
Figure 50. Europe Diagnostic Radiopharmaceuticals Revenue Share by Country (2019-2030)
Figure 51. Europe Diagnostic Radiopharmaceuticals Sales Share by Country (2019-2030)
Figure 52. China Diagnostic Radiopharmaceuticals Revenue Share by Type (2019-2030)
Figure 53. China Diagnostic Radiopharmaceuticals Sales Share by Type (2019-2030)
Figure 54. China Diagnostic Radiopharmaceuticals Revenue Share by Application (2019-2030)
Figure 55. China Diagnostic Radiopharmaceuticals Sales Share by Application (2019-2030)
Figure 56. Asia Diagnostic Radiopharmaceuticals Revenue Share by Type (2019-2030)
Figure 57. Asia Diagnostic Radiopharmaceuticals Sales Share by Type (2019-2030)
Figure 58. Asia Diagnostic Radiopharmaceuticals Revenue Share by Application (2019-2030)
Figure 59. Asia Diagnostic Radiopharmaceuticals Sales Share by Application (2019-2030)
Figure 60. Asia Diagnostic Radiopharmaceuticals Revenue Share by Country (2019-2030)
Figure 61. Asia Diagnostic Radiopharmaceuticals Sales Share by Country (2019-2030)
Figure 62. MEALA Diagnostic Radiopharmaceuticals Revenue Share by Type (2019-2030)
Figure 63. MEALA Diagnostic Radiopharmaceuticals Sales Share by Type (2019-2030)
Figure 64. MEALA Diagnostic Radiopharmaceuticals Revenue Share by Application (2019-2030)
Figure 65. MEALA Diagnostic Radiopharmaceuticals Sales Share by Application (2019-2030)
Figure 66. MEALA Diagnostic Radiopharmaceuticals Revenue Share by Country (2019-2030)
Figure 67. MEALA Diagnostic Radiopharmaceuticals Sales Share by Country (2019-2030)
Figure 68. Diagnostic Radiopharmaceuticals Value Chain
Figure 69. Manufacturing Cost Structure
Figure 70. Diagnostic Radiopharmaceuticals Production Mode & Process
Figure 71. Direct Comparison with Distribution Share
Figure 72. Distributors Profiles
Figure 73. Years Considered
Figure 74. Research Process
Figure 75. Key Executives Interviewed
